Importer of Controlled Substances Application: Wedgewood Village Pharmacy, LLC, 38916-38917 [2024-10032]

Download as PDF 38916 Federal Register / Vol. 89, No. 90 / Wednesday, May 8, 2024 / Notices accomplishments and contributions which support their selection for a second term. Again, reappointment is NOT guaranteed. All nominations must designate which stakeholder group or community the nominee will represent (see Membership Criteria above, for stakeholder groups and required qualifications). All required documents and any letters of support must be submitted in a SINGLE nomination package. Incomplete packets, packets missing the nominee’s contact information, or those with documents submitted separately WILL NOT be considered. Nominations must be received no later than June 7, 2024. Electronic nomination packages are preferred and should be sent to invasive_species@ ios.doi.gov. As necessary, hard copy nominations can be sent to Stanley W. Burgiel, Executive Director, National Invasive Species Council (OS/NISC), Regular Mail: 1849 C Street NW (Mailstop 3530), Washington, DC, 20240. Authority: 5 U.S.C. ch. 10. Stanley W. Burgiel, Executive Director, National Invasive Species Council. [FR Doc. 2024–09999 Filed 5–7–24; 8:45 am] BILLING CODE 4334–63–P INTERNATIONAL TRADE COMMISSION By order of the Commission. Issued: May 2, 2024. Sharon Bellamy, Supervisory Hearings and Information Officer. [Investigation No. 731–TA–1626 (Final)] Paper Shopping Bags From Turkey; Determination [FR Doc. 2024–10005 Filed 5–7–24; 8:45 am] developed On the basis of the in the subject investigation, the United States International Trade Commission (‘‘Commission’’) determines, pursuant to the Tariff Act of 1930 (‘‘the Act’’), that an industry in the United States is materially injured by reason of imports of paper shopping bags from Turkey, provided for in subheadings 4819.30.00 and 4819.40.00 of the Harmonized Tariff Schedule of the United States, that have been found by the U.S. Department of Commerce (‘‘Commerce’’) to be sold in the United States at less than fair value (‘‘LTFV’’).2 record 1 lotter on DSK11XQN23PROD with NOTICES1 BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration The Commission instituted this investigation effective May 31, 2023, following receipt of a petition filed with 1 The record is defined in § 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). 2 89 FR 19295 (March 18, 2024). 17:03 May 07, 2024 Jkt 262001 applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before June 7, 2024. Such persons may also file a written request for a hearing on the application on or before June 7, 2024. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on April 15, 2024, Wedgewood Village Pharmacy, LLC, 7631 East Indian School Road, Suite 201, Scottsdale, Arizona 85251–3607, applied to be registered as an importer of the following basic class(es) of controlled substance(s): [Docket No. DEA–1364] Importer of Controlled Substances Application: Wedgewood Village Pharmacy, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. Controlled substance Etorphine HCL ................. Thiafentanil ...................... AGENCY: Wedgewood Village Pharmacy, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and SUMMARY: Background VerDate Sep<11>2014 the Commission and Commerce by the Coalition for Fair Trade in Shopping Bags, a coalition whose members include Novolex Holdings, LLC, Charlotte, North Carolina, and the United Steel, Paper and Forestry, Rubber, Manufacturing, Energy, Allied Industrial and Service Workers International Union, Pittsburgh, Pennsylvania. The Commission scheduled the final phase of the investigation following notification of a preliminary determination by Commerce that imports of paper shopping bags from Turkey were being sold at LTFV within the meaning of § 733(b) of the Act (19 U.S.C. 1673b(b)). Notice of the scheduling of the final phase of the Commission’s investigation and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of January 18, 2024 (89 FR 3424). The Commission conducted its hearing on March 14, 2024. The Commission made this determination pursuant to § 735(b) of the Act (19 U.S.C. 1673d(b)). It completed and filed its determination in this investigation on May 2, 2024. The views of the Commission are contained in USITC Publication 5504 (May 2024), entitled Paper Shopping Bags from Turkey: Inv. No. 731–TA–1626 (Final). PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 I Drug code Schedule 9059 9729 II II I The company plans to import the listed controlled substances for distribution to their customers. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non- E:\FR\FM\08MYN1.SGM 08MYN1 38917 Federal Register / Vol. 89, No. 90 / Wednesday, May 8, 2024 / Notices approved finished dosage forms for commercial sale. Marsha Ikner, Acting Deputy Assistant Administrator. [FR Doc. 2024–10032 Filed 5–7–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE [OMB Number 1125–0003] Agency Information Collection Activities; Proposed eCollection; eComments Requested; Extension of a Previously Approved Collection; Fee Waiver Request (EOIR–26A) Executive Office for Immigration Review, Department of Justice. ACTION: 30-Day notice. AGENCY: The Executive Office for Immigration Review (EOIR), Department of Justice (DOJ), will be submitting the following information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 30 days until June 7, 2024. ADDRESSES: Written comments and recommendations for this information collection should be submitted within 30 days of the publication of this notice on the following website www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function and entering either the title of the information collection or the OMB Control Number 1125–0003. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, SUMMARY: suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Raechel Horowitz, Chief, Immigration Law Division, Office of Policy, Executive Office for Immigration Review, 5107 Leesburg Pike, Suite 2500, Falls Church, VA 22041, telephone: (703) 305–0473, Raechel.Horowitz@ usdoj.gov. SUPPLEMENTARY INFORMATION: This proposed information collection was previously published in the Federal Register on February 27, 2024, allowing for a 60-day comment period. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and/or —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1. Type of Information Collection: Extension of a currently approved collection. 2. The Title of the Form/Collection: Fee Waiver Request. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: The form number is EOIR–26A, Executive Office for Immigration Review, United States Department of Justice. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Primary: An individual submitting an appeal or motion to the Board of Immigration Appeals. An individual submitting an application or motion to the Office of the Chief Immigration Judge. Attorneys and qualified representatives representing an alien in immigration proceedings before EOIR. The obligation to respond is required to obtain/retain a benefit (fee waiver). Abstract: The information on the fee waiver request form is used by the Board of Immigration Appeals and the Office of the Chief Immigration Judge to determine whether the requisite fee for an application, motion or appeal will be waived due to an individual’s financial situation. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The estimated number of respondents for the Form EOIR–26A is 2,124. The estimated time per response is 1 hour. 6. An estimate of the total public burden (in hours) associated with the collection: The total annual burden hours for this collection is 2,124 hours. 7. An estimate of the total annual cost burden associated with the collection, if applicable: There are no capital or startup costs associated with this information collection. The estimated public cost is zero. TOTAL BURDEN HOURS Number of respondents lotter on DSK11XQN23PROD with NOTICES1 Activity Time per response (hour) Total annual responses Frequency Total annual burden (hours) Form EOIR–26A ............................... 2,124 1/annually ......................................... 2,124 1 2,124 Unduplicated Totals ................... 2,124 ........................................................... 2,124 ........................ 2,124 If additional information is required contact: Darwin Arceo, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution VerDate Sep<11>2014 17:03 May 07, 2024 Jkt 262001 Square, 145 N Street NE, 4W–218, Washington, DC. Dated: May 5, 2024. Darwin Arceo, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2024–09991 Filed 5–7–24; 8:45 am] BILLING CODE 4410–30–P PO 00000 Frm 00057 Fmt 4703 Sfmt 9990 E:\FR\FM\08MYN1.SGM 08MYN1

Agencies

[Federal Register Volume 89, Number 90 (Wednesday, May 8, 2024)]
[Notices]
[Pages 38916-38917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-10032]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1364]


Importer of Controlled Substances Application: Wedgewood Village 
Pharmacy, LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Wedgewood Village Pharmacy, LLC has applied to be registered 
as an importer of basic class(es) of controlled substance(s). Refer to 
SUPPLEMENTARY INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
June 7, 2024. Such persons may also file a written request for a 
hearing on the application on or before June 7, 2024.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on April 15, 2024, Wedgewood Village Pharmacy, LLC, 7631 
East Indian School Road, Suite 201, Scottsdale, Arizona 85251-3607, 
applied to be registered as an importer of the following basic 
class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Etorphine HCL...........................    9059  II
Thiafentanil............................    9729  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
distribution to their customers. No other activities for these drug 
codes are authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-

[[Page 38917]]

approved finished dosage forms for commercial sale.

Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-10032 Filed 5-7-24; 8:45 am]
BILLING CODE P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.